The National Institute of Hygiene and Epidemiology, Veitnam Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT01377571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

The National Institute of Hygiene and Epidemiology

Active Ingredients

Drugs in Phase 3 Trials (2)

matrix m1 (1 trial)

rotavin (1 trial)

Drugs in Phase 2 Trials (1)

human rotavirus, live attenuated (Rotarix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Nausea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3